Narrowband UVB Light Therapy for Chronic Skin Conditions

Light therapy, also known as phototherapy, is a valuable treatment option for various chronic skin conditions. This therapy involves exposing the skin to specific wavelengths of ultraviolet (UV) light to alleviate symptoms and improve skin health.

For chronic conditions like psoriasis and eczema, phototherapy, particularly narrowband UVB (NB-UVB) light, has been proven effective. NB-UVB light slows down the rapid skin cell growth associated with these conditions, reducing inflammation and scaling. Decades of use have demonstrated that regular treatments can lead to significant improvement in skin clarity and reduce the frequency of painful, embarrassing flare-ups.

Vitiligo, a chronic condition causing loss of skin color, can also benefit from light therapy. In this case, UVB light therapy can stimulate the production of melanin, the pigment responsible for skin color. By targeting specific areas of the skin, this therapy can help re-pigment affected areas and restore a more even skin tone.

Zerigo’s Skin Health Program for People with Chronic Skin Conditions

The Zerigo Skin Health Program is reinventing treatment for chronic skin conditions like Atopic dermatitis by harnessing the proven power of narrowband UVB phototherapy in a portable, handheld device1 backed by a holistic care program – at no cost to you¹.

Convenient Care

Free yourself from the pain and disruption of living with a chronic skin condition. The Zerigo Skin Health Program makes treatment painless, hassle-free, and convenient from anywhere, at any time that works for you.

Tailored Treatment

Your skin condition is unique to you. That’s why every Zerigo treatment plan is tailored to meet you where you are today and get you on the road to clearer skin—fast.

Proven Results

Break the trial-and-error treatment cycle. Used as a standalone treatment or in combination with advanced therapies, narrowband UVB phototherapy is a proven approach2 to deliver maximum clearance without the side effects.

Why should you consider using the Zerigo Skin Health Program to treat your atopic dermatitis?

More than 25 years of clinical data² support NB-UVB as one of the most effective treatments for psoriasis, atopic dermatitis, and vitiligo
Light therapy improves skin by calming overactive immune cells, decreasing inflammation, and promoting normal skin barrier growth³
Light therapy produces minimal side-effects and immune system suppression

In a 2021 study, 94% of patients with psoriasis achieve clearance in 30 phototherapy treatments⁷
Zerigo Health has a 4.9/5 member satisfaction rating
More than 95% of our patients say Zerigo’s Skin Health Program is easy to use⁸
People with psoriasis are more likely to follow Zerigo’s treatment program than those who inject biologics or take pills.¹⁰

Love the [Zerigo] system…I began noticing results within 6 weeks and it completely healed around the 3-month mark. I can finally leave my house embarrassment-free and make-up free again.

Amy Patient

Love how the app tells me when it’s time to treat!

Michelle P Patient

Clear skin without psoriasis? It’s the best!

Emily Patient

It’s been one of the only things that has helped clear my psoriasis. I’m so happy that I finally found something that works for me!

Kim Patient

It’s been one of the only things that has helped clear my psoriasis. I’m so happy that I finally found something that works for me.

Richard S Patient

References & Disclaimers

¹The Zerigo Health Phototherapy System is an ultraviolet-light-emitting medical device. It is intended for use in localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). The device can be used in the comfort of a patient’s home or in a physician’s office. Individual results may vary. U.S. federal law restricts this device to sale by or on the order of a physician.

²See, e.g., Elmets CA, et al., Joint American Academy of Dermatology: National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy, 2019 Sep;81(3):775-804; Myers E, Kheradmand S, Miller R. An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases. Cureus. 2021 Nov 1;13(11):e19182.

³Springer Dermatological Research; Adjunctive Treatment of Atopic Dermatitis with Novel At-Home Handheld Narrow-Band UVB Phototherapy

⁴The Zerigo Health Solution is available through your healthcare benefits as a value-added service. You may have to pay a copay or coinsurance if you see your doctor to get a prescription for phototherapy treatment.

⁵Zerigo Care Guides include RNs, MAs, and certified health and wellness coaches who can help coordinate and facilitate your discussion with your doctor. The Care Guides do not prescribe therapies or provide patient-specific medical advice. For questions about your prescription or treatment plan, please contact your doctor.

⁶Offered in conjunction with independent virtual care provider, CirrusMD.

⁷Cutis, Phototherapy: Safe and Effective for Chronic skin conditions in older adults

⁸Zerigo Health member survey, conducted May 2020

⁹Springer Dermatological Research; Adjunctive Treatment of Atopic Dermatitis with Novel At-Home Handheld Narrow-Band UVB Phototherapy

¹⁰Journal of Dermatological Treatment; Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies

¹¹Journal of Drugs in Dermatology; The Impact of At-Home Narrow-Band UVB Phototherapy for Mild-to-Severe Psoriasis

¹²Based on third party actuarial data on chronic skin condition advanced therapy costs among 30 million commercial plan members

¹³Estimated average return on investment (ROI) for commercial member with psoriasis. In analysis of claims cost of 30 million commercial health plan members, projected ROI vary from 3x-15x depending on diagnosis and advanced therapies used.

¹⁴One year pilot with large national PBM conducted with commercial health plan members

¹⁵CirrusMD website

¹⁶Danesh et al, 2015 and Anderson et al, 2015

¹⁷Journal of Managed Care & Specialty Pharmacy, The Direct and Indirect Costs of Atopic Dermatitis

¹⁸National Institutes of Health, Burden of Atopic Dermatitis in Adults and Adolescents

Menu